| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $40,275,192 ) (Continued on the next page) |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL184013 | B-1a Cells and Acute Inflammation | 000 | 1 | NIH | 5/19/2026 | $586,866 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | RF1AG091371 | Neurotoxic Astrocytes and Alzheimer's Disease | 000 | 1 | NIH | 5/7/2026 | $2,557,950 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM163879 | Modulation of innate immune niche for surgical stress-triggered sterile inflammation | 000 | 1 | NIH | 7/3/2026 | $460,625 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R25AG094542 | STAGE TRIALS: Stage-model Training Approaches for Guiding Effective Translation of behavioral Research Interventions in Aging TriaLS | 000 | 2 | NIH | 7/10/2026 | $350,813 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH141228 | Examining the Interplay of Clinical Symptoms, Neurocognition, Functioning, and Stressful Events in Individuals at Clinical High Risk for Developing Psychosis: A Network Analysis Approach | 000 | 1 | NIH | 7/27/2026 | $460,625 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AI196430 | Maturation and maintenance of the germinal center niche | 000 | 1 | NIH | 2/10/2026 | $460,625 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13NS151464 | 2026 International Symposium on Neural Regeneration | 000 | 1 | NIH | 7/20/2026 | $20,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R50LM015185 | Scaling clinical wearable foundation models for the detection of in-hospital deterioration | 000 | 1 | NIH | 6/25/2026 | $139,836 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AG098778 | Mechanistic Underpinnings of Trigeminal Nerve Stimulation for Enhancing Neuropsychological Function in Dementia | 000 | 1 | NIH | 8/14/2026 | $460,625 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH140013 | Vital Signs for Psychosis: Personalized Longitudinal Markers of Psychosis Severity Using Automated Speech and Language Analysis | 000 | 2 | NIH | 7/10/2026 | $817,859 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K08AI193352 | Comparison of the Dysregulated and Regulated Host Responses to Infection | 001 | 2 | NIH | 8/18/2026 | $162,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P01AI073693 | Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | 000 | 17 | NIH | 6/25/2026 | $2,560,412 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 000 | 8 | NIH | 3/23/2026 | $418,750 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P01MH139136 | Early-Phase Psychosis: Practice-Based Research to Improve Treatment Outcomes | 000 | 2 | NIH | 6/23/2026 | $1,503,322 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AI193493 | MSP68 as an effective radiation countermeasure | 000 | 2 | NIH | 6/19/2026 | $167,500 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UH3OD035532 | The Environmental Factors in FEtal to Childhood Trajectories Cohort | 000 | 4 | NIH | 7/6/2026 | $6,338,152 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23DK132459 | Using Digital Solutions to Improve Transition of Care for Patients with Acute Kidney Injury | 000 | 5 | NIH | 3/25/2026 | $188,293 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U01AI170018 | Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures | 001 | 5 | NIH | 7/9/2026 | $418,748 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U01AI170018 | Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures | 000 | 5 | NIH | 6/1/2026 | $775,175 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35HL171168 | Cellular and Molecular Control of Normal and Disordered Erythropoiesis | 001 | 3 | NIH | 6/4/2026 | $26,116 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35HL171168 | Cellular and Molecular Control of Normal and Disordered Erythropoiesis | 000 | 3 | NIH | 2/13/2026 | $827,016 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH117646 | Cognitive Genomics as a Window on Neurodevelopment and Psychopathology | 000 | 8 | NIH | 2/10/2026 | $631,056 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U19AI144306 | A mechanistic understanding of B cell and macrophage plasticity in lupus disease activity states | 000 | 8 | NIH | 5/26/2026 | $637,832 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH137681 | 4/5-Clinical Outcome Prediction of Psychosis from EHRs (COPPER) | 000 | 3 | NIH | 7/15/2026 | $427,234 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 001 | 17 | NIH | 4/23/2026 | $16,245 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 000 | 17 | NIH | 2/23/2026 | $514,454 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23HL163498 | Leveraging Heath Information Technology to Improve Post-Discharge Management for Patients with Heart Failure | 000 | 4 | NIH | 5/12/2026 | $191,683 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latino Mental Health/American Society of Hispanic Psychiatry | 000 | 4 | NIH | 3/5/2026 | $10,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latino Mental Health/American Society of Hispanic Psychiatry | 000 | 4 | NIH | 3/5/2026 | $20,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AR083159 | Brain neural networks regulating inflammation | 000 | 4 | NIH | 8/19/2026 | $579,189 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AG076888 | Increasing Meaning to Reduce Loneliness in Care Partners of Persons with AD/ADRD | 000 | 5 | NIH | 8/14/2026 | $122,508 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AI179476 | Defining molecular pathways triggered by IL-10 and TGFb that drive HIV integration and persistence in Tfh cells in lymph nodes | 001 | 4 | NIH | 8/20/2026 | $698,011 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH137501 | Cerebellar-Cortical Circuitry and Treatment Response in Early Psychosis | 000 | 2 | NIH | 6/16/2026 | $460,066 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23HL159326 | StEP OUT | 000 | 5 | NIH | 7/29/2026 | $151,157 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UH3OD035513 | Developmental Impact of NICU Exposures (DINE) phase II | 000 | 4 | NIH | 7/6/2026 | $889,982 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NR020774 | Optimization of monitoring, prediction and phenotyping of deterioration of inhospital patients using machine learning and multimodal real time data | 000 | 4 | NIH | 5/22/2026 | $783,843 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AG087104 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD) | 001 | 2 | NIH | 2/25/2026 | $82,142 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AG087104 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD) | 000 | 2 | NIH | 1/30/2026 | $739,292 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | P30AG063786 | Northwell Roybal Center for Personalized Trials: Physical Activity Promotion for Persons Giving Care or Living with AD/ADRD | 000 | 7 | NIH | 6/5/2026 | $1,241,971 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NS113893 | Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor after successful Deep Brain Stimulation to the dentato-rubrothalamic tract | 000 | 6 | NIH | 6/30/2026 | $363,857 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AG078496 | Tau networks in AD psychosis | 000 | 5 | NIH | 5/18/2026 | $106,439 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL139778 | Therapeutic Potential of ALK1 Activating Drugs in HHT Models | 000 | 6 | NIH | 3/27/2026 | $558,494 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R24AG064191 | Roybal Resource and Coordinating Center to Accelerate Translational Aging Research | 000 | 8 | NIH | 7/6/2026 | $733,714 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM118337 | Novel Approaches to Maintaining Organ Function in Sepsis | 000 | 10 | NIH | 6/26/2026 | $508,781 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 003 | 4 | NIH | 5/12/2026 | $9,582 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 002 | 4 | NIH | 4/28/2026 | -$9,584 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 001 | 4 | NIH | 3/27/2026 | $711,803 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AA023146 | Role of Beta Spectrin and Smad in Alcohol-Induced Liver and GI Cell Proliferation | 000 | 20 | NIH | 8/11/2026 | $443,383 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM157197 | T Cell Receptor Mediated T Cell Activation in Neonatal and Pediatric Sepsis | 001 | 2 | NIH | 3/20/2026 | $41,875 |
|
